Cancer: Bispecific antibody directs T cells to solid tumours
Nature Reviews Drug Discovery 16, 826 (2017).
doi:10.1038/nrd.2017.237
Author: Megan Cully
Using T cells to attack solid tumours is an attractive option for the treatment of cancer, but requires the presence of a neoantigen on the tumour to engage the T cell. A new paper from Chugai Pharmaceutical uses a bispecific antibody, ERY974, to direct T
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Megan Cully Tags: Research Highlight Source Type: research